K M Cherian's Heart Foundation gets DCGA nod for tissue devp

Image
Press Trust of India Chennai
Last Updated : Dec 13 2013 | 4:47 PM IST
Drug Controller General of India has given an approval to a city-based health care service provider to develop and manufacture tissues used for the treatment of unmet medical needs.
The approval has been given to Chennai-based Dr K M Cherian's Heart Foundation and Frontier Lifeline Hospital to develop and manufacture Tissue Engineered Porcine Pulmonary artery (tePPA), Tissue Engineered Bovine Jugular vein (teBJV) and Tissue Engineered Bovine pericardium (teBP), a release here said.
"Now that we have got approval from the directorate, the trial will be done and the manufactured tissues will be sent to some of the leading colleges like AIIMS, JIPMER, for clinical tests," Fronter Lifeline Hospital and Heart Foundation CEO and Chairman Dr K M Cherian said.
Once the tests have been completed, Frontier Lifeline Hospital and Dr K M Cherian's Heart Foundation would manufacture and supply the tissues, he said.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 13 2013 | 4:47 PM IST

Next Story